About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Wearable Devices on Health Promotion in Diabetes | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT07144774

Wearable Devices on Health Promotion in Diabetes

This proposed study involves human participants who will be prospectively randomized into either 1) intervention group with a activity tracker or 2) control group without an activity tracker. In addit...

Lead sponsor: Pacific University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pacific University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. 18 years of age or older
•2. diagnosed with type 2 diabetes (HbA1c ≥ 6.5% or fasting plasma glucose ≥ 126 mg/dL)
•3. willing to link a fitness tracker (Fitbit®) App to their own smartphone

Exclusion Criteria

•1. are unable to walk without assistive devices,
•2. are current smokers,
•3. are pregnant or breastfeeding,
•4. already engage in ≥ 150 minutes of moderate-to-vigorous physical activity per week,
•5. have any medical conditions (e.g., musculoskeletal diseases, cognitive dysfunction) that will interfere with physical activity,
•6. undergo any insulin treatment.

Related studies

RECRUITINGPhase 1

Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.

NCT07224334 · Diabetes (DM)

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

NCT07351786 · Diabetes (DM), Retinopathy, Diabetic, and more

Identifying Diabetes and Impaired Glucose Tolerance in ICU Patients

NCT07261865 · Diabetes (DM), Critical Illness

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

NCT07237451 · CKD - Chronic Kidney Disease, Heart Failure Preserved Ejection Fraction, and more

Enrolling By Invitation

Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI)

NCT07378891 · Diabetes (DM), Prediabetes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 27, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment9

Start dateFeb 2024

Last updatedAug 27, 2025

Condition

Locations shown

Pacific University

Hillsboro, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 27, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions